$XLABW
Exascale Labs Holdings Inc.
CIK:0002109869|SEC Filings
STATEMENT OF OPERATIONS - USD ($) |
12 Months Ended | |||
|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
|||
| Income Statement [Abstract] | ||||
| Revenues | $ 14,822,799 | $ 7,015,512 | ||
| Cost of revenues | (12,404,546) | (5,910,315) | ||
| Gross profit | 2,418,253 | 1,105,197 | ||
| Operating expenses | ||||
| Selling and marketing expenses | (499,392) | (989,155) | ||
| General and administrative expenses | (1,229,516) | (362,982) | ||
| Research and development expenses | (5,490,185) | (2,797,906) | ||
| Total operating expenses | (7,219,093) | (4,150,043) | ||
| Loss from operations | (4,800,840) | (3,044,846) | ||
| Change in fair value of simple agreements for future equity | (7,377,383) | (4,614,821) | ||
| Other income | 15,832 | |||
| Loss before income tax expenses | (12,162,391) | (7,659,667) | ||
| Income tax expenses | ||||
| Net loss and total comprehensive loss | $ (12,162,391) | $ (7,659,667) | ||
| Loss per share | ||||
| Basic Loss per share | $ (8,108.26) | $ (5,106.44) | ||
| Diluted Loss per share | $ (8,108.26) | $ (5,106.44) | ||
| Weighted average number of shares used to compute loss per share | ||||
| Weighted average number of shares used to compute loss per share Basic | [1] | 1,500 | 1,500 | |
| Weighted average number of shares used to compute loss per share Diluted | [1] | 1,500 | 1,500 | |
| ||||